Tested split-course chemo radiation for cervical cancer side effects
Part of Cancer, Women’s health & pregnancy clinical trials.
This Phase 2 trial looks at a “split” (hypo-fractionated) schedule of chemotherapy plus radiation for cervical cancer, followed by brachytherapy. It aims to see how well the treatment works and what side effects happen, especially toxicity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cervical cancer is one of these types: squamous cell, adenocarcinoma, or adenosquamous
- Your cancer stage is FIGO IB, IIA, IIB, IIIA, IIIB, or IIIC1 under specific lymph-node limits
- You are planned to receive full, definitive chemoradiotherapy plus brachytherapy
- Your kidney function (creatinine clearance) must be at least 30 mL/min
- You have not had pelvic radiation before, and you have not had a hysterectomy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation combined with chemotherapy and brachytherapy (internal radiation) for cervical cancer that has not spread widely. It aims to make treatment more efficient while still being effective.
This trial tests a new way of delivering radiation therapy (brachytherapy) combined with chemotherapy for advanced cervical cancer. The goal is to see if a faster, more intense radiation schedule is safe and effective.
This trial tests a shorter course of radiation combined with chemotherapy (hypofractionated radiochemotherapy) for women with advanced cervical cancer. It may help reduce treatment time while still effectively targeting the tumor.
This trial tests a shorter course of radiation combined with chemotherapy for locally advanced cervical cancer. It aims to see if fewer radiation sessions can be just as effective while reducing side effects.
This trial tests a combination of pelvic chemoradiation (chemotherapy and radiation) with a special type of brachytherapy (internal radiation) that adjusts the dose during treatment for locally advanced cervical cancer. It aims to improve tumor control while keeping side effects manageable.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
Hear when a new Cervix Uteri Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.